Quantitative nanostructure-activity relationship modeling.

Evaluation of biological effects, both desired and undesired, caused by manufactured nanoparticles (MNPs) is of critical importance for nanotechnology. Experimental studies, especially toxicological, are time-consuming, costly, and often impractical, calling for the development of efficient computational approaches capable of predicting biological effects of MNPs. To this end, we have investigated the potential of cheminformatics methods such as quantitative structure-activity relationship (QSAR) modeling to establish statistically significant relationships between measured biological activity profiles of MNPs and their physical, chemical, and geometrical properties, either measured experimentally or computed from the structure of MNPs. To reflect the context of the study, we termed our approach quantitative nanostructure-activity relationship (QNAR) modeling. We have employed two representative sets of MNPs studied recently using in vitro cell-based assays: (i) 51 various MNPs with diverse metal cores (Proc. Natl. Acad. Sci. 2008, 105, 7387-7392) and (ii) 109 MNPs with similar core but diverse surface modifiers (Nat. Biotechnol. 2005, 23, 1418-1423). We have generated QNAR models using machine learning approaches such as support vector machine (SVM)-based classification and k nearest neighbors (kNN)-based regression; their external prediction power was shown to be as high as 73% for classification modeling and having an R(2) of 0.72 for regression modeling. Our results suggest that QNAR models can be employed for: (i) predicting biological activity profiles of novel nanomaterials, and (ii) prioritizing the design and manufacturing of nanomaterials toward better and safer products.

[1]  J. Farber,et al.  ATP depletion and loss of cell integrity in anoxic hepatocytes and silica-treated P388D1 macrophages. , 1985, The American journal of physiology.

[2]  Alexander Tropsha,et al.  Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..

[3]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[4]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[5]  A. Tropsha,et al.  Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. , 2003, Journal of medicinal chemistry.

[6]  John M. Barnard,et al.  Clustering Methods and Their Uses in Computational Chemistry , 2003 .

[7]  Jenny R. Roberts,et al.  PbCrO4 mediates cellular responses via reactive oxygen species , 2004, Molecular and Cellular Biochemistry.

[8]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[9]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[10]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[11]  J. Oh,et al.  Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles , 2005, Pharmaceutical Research.

[12]  Debra L Laskin,et al.  Smaller is not always better: nanotechnology yields nanotoxicology. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[13]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.

[14]  Zoran Markovic,et al.  Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. , 2007, European journal of pharmacology.

[15]  H. Krug,et al.  Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. , 2007, Toxicology letters.

[16]  Dana Martin,et al.  QSPR modeling of solubility of polyaromatic hydrocarbons and fullerene in 1-octanol and n-heptane. , 2007, The journal of physical chemistry. B.

[17]  Zoran Markovic,et al.  Modulation of Tumor Necrosis Factor-mediated Cell Death by Fullerenes , 2008, Pharmaceutical Research.

[18]  B. Karn,et al.  Green Nanotechnology: It’s Easier than You Think , 2007 .

[19]  I. Tetko,et al.  ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors , 2008 .

[20]  Igor V. Tetko,et al.  Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection , 2008, J. Chem. Inf. Model..

[21]  Aravind Subramanian,et al.  Perturbational profiling of nanomaterial biologic activity , 2008, Proceedings of the National Academy of Sciences.

[22]  Igor V. Tetko,et al.  Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis , 2008, J. Chem. Inf. Model..

[23]  Mary Gulumian,et al.  The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles , 2009, Particle and Fibre Toxicology.

[24]  Su Jin Kang,et al.  Titanium dioxide nanoparticles trigger p53‐mediated damage response in peripheral blood lymphocytes , 2008, Environmental and molecular mutagenesis.

[25]  Jianzhong Liu,et al.  Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure--activity relationship analysis. , 2008, Chemical research in toxicology.

[26]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[27]  T. Puzyn,et al.  Toward the development of "nano-QSARs": advances and challenges. , 2009, Small.

[28]  Bryce J Marquis,et al.  Analytical methods to assess nanoparticle toxicity. , 2009, The Analyst.

[29]  Pawel L Urban,et al.  Nanoparticles: their potential toxicity, waste and environmental management. , 2009, Waste management.

[30]  Anton J Hopfinger,et al.  Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor? , 2009, Molecular pharmaceutics.

[31]  JF Nyland,et al.  A nanobiological approach to nanotoxicology , 2009, Human & experimental toxicology.

[32]  M. Heinemann,et al.  Guidance for handling and use of nanomaterials at the workplace , 2009, Human & experimental toxicology.

[33]  Yoo-Hun Suh,et al.  Nanotechnology, nanotoxicology, and neuroscience , 2009, Progress in Neurobiology.

[34]  Saji George,et al.  A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.

[35]  T. Xia,et al.  Potential health impact of nanoparticles. , 2009, Annual review of public health.

[36]  V. Kagan,et al.  The role of nanotoxicology in realizing the ‘helping without harm’ paradigm of nanomedicine: lessons from studies of pulmonary effects of single‐walled carbon nanotubes , 2010, Journal of internal medicine.

[37]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[38]  Alexander Tropsha,et al.  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. , 2010, Chemical research in toxicology.

[39]  Lenore L. Dai,et al.  Understanding nanoparticle diffusion and exploring interfacial nanorheology using molecular dynamics simulations. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[40]  G. Oberdörster,et al.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.